Mazurkiewicz Maria, Brzozowska Anna, Mazurkiewicz Tomasz, Grzybowska-Szatkowska Ludmiła
Katedra i Zakład Onkologii, Akademii Medycznej w Lublinie.
Pol Merkur Lekarski. 2004 Jan;16(91):26-30.
Prognostic survival rate is one of the factors decisive about the kind of the local therapy at patients with bone metastases. The work evaluates chosen prognostic parameters such as age, sex, the presence of extra-skeletal metastases, the existence of pathological fracture and the applications of bisphosphonates and/or systemic treatment at 305 patients irradiated due to bone metastases. The median survival rate was 6.2 months and was significantly depended from primary location of the disease. The sex, age and number of metastatic foci had no significant influence on the median survival rate however the remaining prognostic factors depended on the primary location of the neoplasm.
预后生存率是决定骨转移患者局部治疗方式的因素之一。这项研究评估了305例因骨转移接受放疗患者的选定预后参数，如年龄、性别、骨外转移的存在、病理性骨折的存在以及双膦酸盐和/或全身治疗的应用情况。中位生存率为6.2个月，且显著取决于疾病的原发部位。性别、年龄和转移灶数量对中位生存率没有显著影响，然而其余预后因素则取决于肿瘤的原发部位。
